Lupin Limited Tops S&P Global ESG Ranking
Analysis based on 7 articles · First reported Feb 27, 2026 · Last updated Mar 06, 2026
This recognition for Lupin Limited is expected to positively impact its stock price and reputation, as strong ESG performance is increasingly valued by investors. It also highlights the growing importance of sustainability benchmarks like those provided by S&P Global in financial markets.
Lupin Limited, a global pharmaceutical company, has been recognized among the top 1% of companies worldwide in the S&P Global Corporate Sustainability Assessment (CSA), achieving a score of 91 out of 100. This places Lupin Limited as the leading pharmaceutical company globally and the leader across all sectors in India, surpassing both Indian and international peers. The company has been included in the Sustainability Yearbook 2026 for the third consecutive year, based on scores from the S&P Global 2025 Corporate Sustainability Assessment. Ramesh Swaminathan, Executive Director, Global CFO and Head of IT and API Plus SBU at Lupin Limited, emphasized the company's long-term commitment to embedding ESG principles into its business strategy and accelerating its sustainability roadmap.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard